Skip to main content

Day: April 15, 2020

National Bank Holdings Corporation Announces Date for 2020 First Quarter Earnings Release

DENVER, April 15, 2020 (GLOBE NEWSWIRE) — National Bank Holdings Corporation (NYSE: NBHC) expects to report its first quarter financial results after the markets close on Tuesday, April 21, 2020. Management will host a conference call to review the results at 11:00 a.m. Eastern Time on Wednesday, April 22, 2020. Interested parties may listen to this call by dialing (877) 272-6762/ (615) 800-6832 (International) using the Conference ID of 1344438 and asking for the NBHC First Quarter Earnings conference call. A telephonic replay of the call will be available beginning approximately four hours after the call’s completion through May 5, 2020, by dialing (855) 859-2056 (United States) / (404) 537-3406 (International) using the Conference ID of 1344438. The earnings release and an on-line replay of the call will also be available on...

Continue reading

Aeterna Zentaris Receives Nasdaq Notice of Non-Compliance; No Immediate Impact on Listing

CHARLESTON, S.C., April 15, 2020 (GLOBE NEWSWIRE) — Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (“Aeterna Zentaris” or the “Company”), a specialty biopharmaceutical company commercializing and developing therapeutics and diagnostic tests, today announced that on April 8, 2020, the Company received notice from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company is not in compliance with the minimum $1.00 per share bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) as the bid price for the Company’s common stock had closed below $1.00 per share for the prior 30 consecutive business day period, and that the Company has been provided a grace period of 180 calendar days, through October 5, 2020, to evidence compliance with that requirement....

Continue reading

Upwork To Report First Quarter 2020 Financial Results on May 6, 2020

SANTA CLARA, Calif., April 15, 2020 (GLOBE NEWSWIRE) — Upwork Inc. (Nasdaq: UPWK), the largest online talent solution, today announced that it will release financial results for the first quarter of 2020 on Wednesday, May 6, 2020 after market close. The company will host a Q&A conference call to discuss these results at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) on the same day.A live webcast of the call will be available on the Upwork Investor Relations website at https://investors.upwork.com.About UpworkUpwork is the leading online talent solution transforming professional staffing. We empower businesses with more flexible access to quality talent, on demand. Through Upwork’s matching technology and services, companies have access to a global pool of proven professionals so they can scale their teams dynamically to meet...

Continue reading

Viper Energy Partners LP, a Subsidiary of Diamondback Energy, Inc., Schedules First Quarter 2020 Conference Call for May 5, 2020

MIDLAND, Texas, April 15, 2020 (GLOBE NEWSWIRE) — Viper Energy Partners LP (NASDAQ: VNOM) (“Viper”), a subsidiary of Diamondback Energy, Inc. (NASDAQ: FANG) (“Diamondback”), today announced that it plans to release first quarter 2020 financial results on May 4, 2020 after the market closes.In connection with the earnings release, Viper will host a conference call and webcast for investors and analysts to discuss its results for the first quarter of 2020 on Tuesday, May 5, 2020 at 10:00 a.m. CT.  Participants should call (844) 400-1537 (United States/Canada) or (703) 326-5198 (International) and use the confirmation code 2595076.  A telephonic replay will be available from 1:00 p.m. CT on Tuesday, May 5, 2020, through Tuesday, May 12, 2020 at 1:00 p.m. CT.  To access the replay, call (855) 859-2056 (United States/Canada) or (404) 537-3406...

Continue reading

VIR-2218 Demonstrates Dose-Dependent and Durable Reductions of Hepatitis B Surface Antigen in Phase 1/2 Trial

SAN FRANCISCO, April 15, 2020 (GLOBE NEWSWIRE) — Vir Biotechnology, Inc. (NASDAQ: VIR) today announced additional interim data from the ongoing Phase 2 trial in patients and results from the Phase 1 trial in healthy volunteers of VIR-2218, an investigational small interfering ribonucleic acid (siRNA) that mediates RNA interference (RNAi) for the treatment of chronic hepatitis B virus (HBV) infection.Interim results from the ongoing Phase 2 trial demonstrate that VIR-2218 results in a significant dose-dependent and durable reduction in hepatitis B surface antigen (HBsAg) through Week 24 in patients with chronic HBV who received two doses of VIR-2218, ranging from 20 mg to 200 mg. Similar HBsAg reductions were observed in both HBeAg- and HBeAg+ patients. In addition, VIR-2218 was generally well tolerated, with the majority of treatment...

Continue reading

Rattler Midstream LP, a Subsidiary of Diamondback Energy, Inc., Schedules First Quarter 2020 Conference Call for May 7, 2020

MIDLAND, Texas, April 15, 2020 (GLOBE NEWSWIRE) — Rattler Midstream LP (NASDAQ: RTLR) (“Rattler”), a subsidiary of Diamondback Energy, Inc. (NASDAQ: FANG) (“Diamondback”), today announced that it plans to release first quarter 2020 financial results on May 6, 2020 after the market closes.In connection with the earnings release, Rattler will host a conference call and webcast for investors and analysts to discuss its results for the first quarter of 2020 on Thursday, May 7, 2020 at 9:00 a.m. CT.  Participants should call (877) 288-2756 (United States/Canada) or (470) 495-9481 (International) and use the confirmation code 3095396.  A telephonic replay will be available from 11:00 a.m. CT on Thursday May 7, 2020 through Thursday, May 14, 2020 at 11:00 a.m. CT.  To access the replay, call (855) 859-2056 (United States/Canada) or (404) 537-3406...

Continue reading

Arcturus Therapeutics Announces Proposed Public Offering of Common Stock

SAN DIEGO, April 15, 2020 (GLOBE NEWSWIRE) — Arcturus Therapeutics Holdings Inc. (the “Company”, NASDAQ: ARCT), a leading messenger RNA medicines company focused on the discovery, development and commercialization of therapeutics for rare diseases and vaccines, today announced that it intends to offer and sell shares of its common stock in an underwritten public offering. All of the shares to be sold in the offering will be offered by the Company. The offering is subject to market conditions and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering. In addition, the Company intends to grant the underwriters a thirty-day option to purchase up to an additional 15 percent of shares of its common stock offered in the public offering.Guggenheim Securities is acting...

Continue reading

Calithera Biosciences, Inc. Announces Commencement of Underwritten Public Offering of Common Stock

SOUTH SAN FRANCISCO, Calif., April 15, 2020 (GLOBE NEWSWIRE) — Calithera Biosciences, Inc. (Nasdaq: CALA), a clinical stage biotechnology company focused on discovering and developing novel small molecule drugs for the treatment of cancer and other life-threatening diseases, today announced that it intends to offer and sell shares of its common stock in an underwritten public offering. All of the shares of common stock are being offered by Calithera. Citigroup is acting as sole book-running manager for the offering. In connection with this offering, Calithera expects to grant Citigroup a 30-day option to purchase an additional 15% of the shares of common stock offered in the public offering.The offering is subject to market conditions, as well as Nasdaq approval, and there can be no assurance as to whether or when the offering may...

Continue reading

Diamondback Energy, Inc. Schedules First Quarter 2020 Conference Call for May 5, 2020

MIDLAND, Texas, April 15, 2020 (GLOBE NEWSWIRE) — Diamondback Energy, Inc. (NASDAQ: FANG) (“Diamondback”), today announced that it plans to release first quarter 2020 financial results on May 4, 2020 after the market closes.In connection with the earnings release, Diamondback will host a conference call and webcast for investors and analysts to discuss its results for the first quarter of 2020 on Tuesday, May 5, 2020 at 8:00 a.m. CT.  Participants should call (877) 440-7573 (United States/Canada) or (253) 237-1144 (International) and use the confirmation code 1072965.  A telephonic replay will be available from 11:00 a.m. CT on Tuesday, May 5, 2020, through Tuesday, May 12, 2020 at 11:00 a.m. CT.  To access the replay, call (855) 859-2056 (United States/Canada) or (404) 537-3406 (International) and enter confirmation code 1072965....

Continue reading

Union Bankshares Announces Earnings for the Three Months Ended March 31, 2020 and Declares Quarterly Dividend

MORRISVILLE, Vt., April 15, 2020 (GLOBE NEWSWIRE) — Union Bankshares, Inc. (NASDAQ – UNB) today announced results for the three months ended March 31, 2020 and declared a regular quarterly cash dividend.Consolidated net income for the first quarter was $2.2 million, or $0.49 per share, compared to $2.6 million, or $0.59 per share, for the same period in 2019.  The reduction in earnings from the 2019 comparison period was due to a combination of factors including an anticipated flat interest rate environment, planned technology infrastructure spending, discretionary hiring of high value staff to allow continued growth in the franchise, continued development of newer branch locations, ongoing competition in all aspects of the business, and the initial impacts of the outbreak of the COVID-19 public health emergency.Interest income...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.